Correlation Between Abcam PLC and Immunome
Can any of the company-specific risk be diversified away by investing in both Abcam PLC and Immunome at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Abcam PLC and Immunome into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Abcam PLC and Immunome, you can compare the effects of market volatilities on Abcam PLC and Immunome and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Abcam PLC with a short position of Immunome. Check out your portfolio center. Please also check ongoing floating volatility patterns of Abcam PLC and Immunome.
Diversification Opportunities for Abcam PLC and Immunome
Pay attention - limited upside
The 3 months correlation between Abcam and Immunome is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Abcam PLC and Immunome in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Immunome and Abcam PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Abcam PLC are associated (or correlated) with Immunome. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Immunome has no effect on the direction of Abcam PLC i.e., Abcam PLC and Immunome go up and down completely randomly.
Pair Corralation between Abcam PLC and Immunome
If you would invest (100.00) in Abcam PLC on December 1, 2024 and sell it today you would earn a total of 100.00 from holding Abcam PLC or generate -100.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 0.0% |
Values | Daily Returns |
Abcam PLC vs. Immunome
Performance |
Timeline |
Abcam PLC |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Immunome |
Abcam PLC and Immunome Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Abcam PLC and Immunome
The main advantage of trading using opposite Abcam PLC and Immunome positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Abcam PLC position performs unexpectedly, Immunome can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Immunome will offset losses from the drop in Immunome's long position.Abcam PLC vs. Anebulo Pharmaceuticals | Abcam PLC vs. Adagene | Abcam PLC vs. Acrivon Therapeutics, Common | Abcam PLC vs. AnaptysBio |
Immunome vs. Anebulo Pharmaceuticals | Immunome vs. Adagene | Immunome vs. Acrivon Therapeutics, Common | Immunome vs. AnaptysBio |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Other Complementary Tools
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |